Pain Bundle - Joint & Muscle Pain Advantage Capsules 30 Pack + Muscle Butter ACTIVE 1.8oz

Pain Bundle - Joint & Muscle Pain Advantage Capsules 30 Pack + Muscle Butter ACTIVE 1.8oz

Joint & Muscle Pain Advantage is a fast-acting formula designed to provide pain support quickly. Each capsules contains 250mg of MSM (methylsulfonylmethane), 210mg of Boswellia Serrata (Indian frankincense), 100mg of Ascorbic Acid (Vitamin C) and 40mg of THC-free CBD (cannabidiol). This powerful capsule should be taken 1-2 times daily to help combat back pain, joint and muscle stiffness and other forms of acute and chronic discomfort. It is THC-Free, WADA-compliant and safe for all competitive sports.  100% VEGAN

Formulated by athletes for athletes, CBD Muscle Butter Active combines CBD (Cannabidiol) with boswellia (frankincense), ginger and cayenne pepper. Our proprietary blend of all-natural ingredients in designed for pre-activity as well as post-activity. It is THC-Free, WADA-compliant and safe for all competitive sports.

$71.50

Additional information

Weight 5 oz
Dimensions 4 × 4 × 4 in

NCBI Studies and Information

We strongly encourage you to do additional research to determine which CBD products are best for you. Due to FDA regulations, we cannot share all of the benefits of cannabidiol, but we can link to reputable, third-party resources that can.  The links below will open up sites outside of hellobluecbd.com in a new tab. If you have any questions, please don’t hesitate to click the blue bubble in the lower right corner to chat with us, or send a message through our contact page.

The Endocannabinoid System

Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389-462. doi:10.1124/pr.58.3.2

Anxiety Relief

Blessing EM, Steenkamp MM, Manzanares J, Marmar CR. Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics. 2015;12(4):825-836. doi:10.1007/s13311-015-0387-1

Bergamaschi MM, Queiroz RH, Chagas MH, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011;36(6):1219-1226. doi:10.1038/npp.2011.6

Crippa JA, Guimarães FS, Campos AC, Zuardi AW. Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. Front Immunol. 2018;9:2009. Published 2018 Sep 21. doi:10.3389/fimmu.2018.02009

Pain Relief

Ryz NR, Remillard DJ, Russo EB. Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain. Cannabis Cannabinoid Res. 2017;2(1):210-216. Published 2017 Aug 1. doi:10.1089/can.2017.0028

Topical Applications (Muscle Butter)

Chen J, Jiang QD, Chai YP, Zhang H, Peng P, Yang XX. Natural Terpenes as Penetration Enhancers for Transdermal Drug DeliveryMolecules. 2016;21(12):1709. Published 2016 Dec 11. doi:10.3390/molecules21121709

Sports Performance

McCartney D, Benson MJ, Desbrow B, Irwin C, Suraev A, McGregor IS. Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research. Sports Med Open. 2020;6(1):27. Published 2020 Jul 6. doi:10.1186/s40798-020-00251-0

General Use in Therapy and Psychiatry

Calapai G, Mannucci C, Chinou I, et al. Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry. Evid Based Complement Alternat Med. 2019;2019:2509129. Published 2019 Aug 29. doi:10.1155/2019/2509129

Elsaid S, Kloiber S, Le Foll B. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings. Prog Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub 2019 Aug 28. PMID: 31601406.

Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F. Cannabidiol (CBD) use in psychiatric disorders: A systematic review. Neurotoxicology. 2019 Sep;74:282-298. doi: 10.1016/j.neuro.2019.08.002. Epub 2019 Aug 11. PMID: 31412258.

Mandolini GM, Lazzaretti M, Pigoni A, Oldani L, Delvecchio G, Brambilla P. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview. Epidemiol Psychiatr Sci. 2018 Aug;27(4):327-335. doi: 10.1017/S2045796018000239. Epub 2018 May 23. PMID: 29789034; PMCID: PMC6998871.

Calapai G, Mannucci C, Chinou I, et al. Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry. Evid Based Complement Alternat Med. 2019;2019:2509129. Published 2019 Aug 29. doi:10.1155/2019/2509129

Reviews

There are no reviews yet.

Be the first to review “Pain Bundle – Joint & Muscle Pain Advantage Capsules 30 Pack + Muscle Butter ACTIVE 1.8oz”

Your email address will not be published. Required fields are marked *